Growth Metrics

Gyre Therapeutics (GYRE) EPS (Basic) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 139.68%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.58%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.28%
7 Evaxion A 62.56 Bn 62.54 Bn - 58.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.92%
10 Gyre Therapeutics 532.38 Mn 518.25 Mn 8.38 Mn -65.10%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -65.10%
Dec 31, 2025 75.00%
Sep 30, 2025 31.04%
Jun 30, 2025 -85.44%
Mar 31, 2025 27.35%
Dec 31, 2024 87.80%
Sep 30, 2024 26.25%
Jun 30, 2024 27.29%
Mar 31, 2024 28.34%
Dec 31, 2023 -20.51%
Sep 30, 2023 27.69%
Jun 30, 2023 26.64%
Mar 31, 2023 28.92%
Dec 31, 2022 -4.24%
Sep 30, 2022 46.76%
Jun 30, 2022 50.75%
Mar 31, 2022 28.53%
Dec 31, 2021 11.71%
Sep 30, 2021 -7.72%
Jun 30, 2021 -5.83%
Mar 31, 2021 -12.15%
Dec 31, 2020 2.86%
Sep 30, 2020 18.33%
Jun 30, 2020 27.60%
Mar 31, 2020 60.58%
Dec 31, 2019 37.60%
Sep 30, 2019 44.01%
Jun 30, 2019 43.36%
Mar 31, 2019 35.57%
Dec 31, 2018 -27.38%
Sep 30, 2018 11.71%
Jun 30, 2018 51.04%
Mar 31, 2018 58.20%
Dec 31, 2017 35.09%
Sep 30, 2017 31.01%
Jun 30, 2017 23.63%
Mar 31, 2017 1.28%
Dec 31, 2016 -126.53%
Sep 30, 2016 -151.43%
Jun 30, 2016 -157.67%
Mar 31, 2016 -169.73%
Dec 31, 2015 1.44%
Sep 30, 2015 -57.07%
Jun 30, 2015 -133.30%
Mar 31, 2015 -381.41%
Dec 31, 2014 -129.60%
Sep 30, 2014 -147.23%
Jun 30, 2014 -332.93%
Mar 31, 2014 -135.41%
Dec 31, 2013 -71.00%
Sep 30, 2013 -83.93%
Jun 30, 2013 -69.23%